Abstract

BackgroundPatients with systemic lupus erythematosus (SLE) have an ongoing interferon (IFN)-α production due to the stimulation of Toll-like receptors (TLR) 7 and 9 in plasmacytoid dendritic cells (pDCs) by immune...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
IFN-α Production by Plasmacytoid Dendritic Cells Stimulated with RNA-Containing Immune Complexes Is Promoted by NK Cells via MIP-1β and LFA-1
Dag Leonard ... Yenan T Bryceson
The Journal of Immunology | VOL. 186
Dag Leonard, et. al.Dag Leonard ... Yenan T Bryceson
01 May 2011
AB0171 THE REGULATION AND PHARMACOLOGICAL MODULATION OF IMMUNE COMPLEX INDUCED PRODUCTION OF TYPE III IFN BY PLASMACYTOID DENDRITIC CELLS
Karin Hjorton ... Lars Ronnblom
-
Karin Hjorton, et. al.Karin Hjorton ... Lars Ronnblom
01 Jun 2019
AB0159 Cytokine production by activated plasmacytoid dendritic cells and nk cells is suppressed by an irak4 inhibitor
J Mo ... E Israelsson
Annals of the Rheumatic Diseases | VOL. 77
J Mo, et. al.J Mo ... E Israelsson
01 Jun 2018
IFN-α production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases.
M.-L Eloranta ... A.-C Syvanen
Human molecular genetics | VOL. 24
M.-L Eloranta, et. al.M.-L Eloranta ... A.-C Syvanen
16 Mar 2015
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers